Cenovus Energy Inc vs Heron Therapeutics Inc — how do they compare? Cenovus Energy Inc trades at $27.59 (market cap $50.90B), while Heron Therapeutics Inc trades at $0.43 (market cap $82.52M). The key difference: Cenovus Energy Inc is far larger — about 616.8× Heron Therapeutics Inc's market cap, and Cenovus Energy Inc pays a 2.25% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| CVE | HRTX | |
|---|---|---|
Market Cap | $50.90B | $82.52M |
Sector | Energy | Health |
52-Week High | $31.80 | $2.04 |
52-Week Low | $13.96 | $0.39 |
Enterprise Value | $58.77B | $180.42M |
Dividend Yield | 2.25% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.42 with a slight 0.6% daily gain, but technical indicators show a bearish trend with moving averages signaling sell pressure. The company reported Q1 2026 revenue of $151M with a net loss of $31M, continuing negative profitability trends. Recent news highlights patent litigation developments and management reaffirming full-year guidance despite quarterly misses.
While analyst consensus remains overwhelmingly bullish (95% buy ratings), fundamental challenges persist with negative earnings and cash flow. Investment opportunity exists if the company can achieve profitability turnaround, but risks include ongoing operational losses, competitive pressures in biotechnology, and patent litigation uncertainties.
Trailing returns across standard periods
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →